Clinical trials: Depot Medroxyprogesterone Acetate
- Condition Depot Medroxyprogesterone Acetate
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Endometriosis
Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis
This study is designed to assess the effects of elagolix versus subcutaneous depot medroxyprogesterone acetate (DMPA-SC; also known as depo-provera) on bone mineral density (BMD) during treatment for 24 weeks with a subsequent…
- Trial name
- PETAL (NCT00437658)
- Testing
- Elagolix, Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)
- Volunteers
- 252 people
- Sponsor
- AbbVie